Skip to main content
. 2025 Mar 23;8(2):37. doi: 10.3390/reports8020037
IBD Inflammatory bowel disease
CD Crohn’s disease
OFG Orofacial granulomatosis
JAK Janus kinase
DTT Dual-targeted therapy
CRP C-reactive protein
GPA Granulomatosis with polyangiitis
IFX Infliximab